Harvard Bioscience Inc (HBIO) — Strategic Asset Allocation Index
Harvard Bioscience Inc (HBIO) has a Strategic Asset Allocation Index of 4.6% as of June 2023. Strategic assets (PP&E of $3.49 Million plus long-term investments of $-) total $3.49 Million, measured against net assets of $75.39 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See HBIO equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Harvard Bioscience Inc Strategic Asset Allocation Index (2000–2022)
This chart shows how Harvard Bioscience Inc's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 4.6%, representing strategic assets of $3.49 Million against net assets of $75.39 Million USD. For live market cap and overall valuation, see Harvard Bioscience Inc (HBIO) market capitalisation.
Annual Strategic Asset Allocation Index for Harvard Bioscience Inc (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Harvard Bioscience Inc from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See HBIO total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 4.7% | $3.37 Million | $3.37 Million | $- | $72.22 Million | ▲ +0.6 pp |
| 2021 | 4.1% | $3.42 Million | $3.42 Million | $- | $83.40 Million | ▼ -1.1 pp |
| 2020 | 5.2% | $3.96 Million | $3.96 Million | $- | $76.68 Million | ▼ -0.7 pp |
| 2019 | 5.8% | $4.78 Million | $4.78 Million | $- | $81.69 Million | ▼ -1.3 pp |
| 2018 | 7.2% | $5.90 Million | $5.90 Million | $- | $82.18 Million | ▲ +2.0 pp |
| 2017 | 5.2% | $4.18 Million | $4.14 Million | $37.00K | $80.90 Million | ▼ -0.8 pp |
| 2016 | 6.0% | $4.30 Million | $4.30 Million | $- | $72.20 Million | ▼ -1.7 pp |
| 2015 | 7.6% | $5.90 Million | $5.90 Million | $- | $77.60 Million | ▲ +2.2 pp |
| 2014 | 5.4% | $5.19 Million | $5.19 Million | $- | $95.47 Million | ▲ +0.8 pp |
| 2013 | 4.6% | $4.38 Million | $4.38 Million | $- | $94.48 Million | ▲ +0.3 pp |
| 2012 | 4.4% | $4.55 Million | $4.55 Million | $- | $104.21 Million | ▲ +1.1 pp |
| 2011 | 3.2% | $3.09 Million | $3.09 Million | $- | $95.50 Million | ▼ -0.3 pp |
| 2010 | 3.5% | $3.15 Million | $3.15 Million | $- | $90.25 Million | ▼ -1.2 pp |
| 2009 | 4.7% | $3.54 Million | $3.54 Million | $- | $75.26 Million | ▼ -0.1 pp |
| 2008 | 4.8% | $3.22 Million | $3.22 Million | $- | $66.72 Million | ▼ -1.2 pp |
| 2007 | 6.0% | $4.46 Million | $4.46 Million | $- | $74.14 Million | ▼ -0.4 pp |
| 2006 | 6.4% | $4.61 Million | $4.61 Million | $- | $71.88 Million | ▲ +0.6 pp |
| 2005 | 5.8% | $3.98 Million | $3.98 Million | $- | $68.42 Million | ▼ -1.0 pp |
| 2004 | 6.8% | $7.14 Million | $7.14 Million | $- | $104.36 Million | ▲ +0.0 pp |
| 2003 | 6.8% | $6.75 Million | $6.75 Million | $- | $98.88 Million | ▲ +0.1 pp |
| 2002 | 6.7% | $5.92 Million | $5.92 Million | $- | $88.38 Million | ▲ +1.4 pp |
| 2001 | 5.2% | $3.51 Million | $3.51 Million | $- | $66.81 Million | ▲ +2.0 pp |
| 2000 | 3.3% | $1.72 Million | $1.72 Million | $- | $52.33 Million | — |